MDC1 maintains active elongation complexes of RNA polymerase II

Description

The role of MDC1 in the DNA damage response has been extensively studied; however, its impact on other cellular processes is not well understood. Here, we describe the role of MDC1 in transcription as a regulator of RNA polymerase II (RNAPII). Depletion of MDC1 causes a genome-wide reduction in the abundance of actively engaged RNAPII elongation complexes throughout the gene body of protein-encoding genes under unperturbed conditions. Decreased engaged RNAPII subsequently alters the assembly of the spliceosome complex on chromatin, leading to changes in pre-mRNA splicing. Mechanistically, the S/TQ domain of MDC1 modulates RNAPII-mediated transcription. Upon genotoxic stress, MDC1 promotes the abundance of engaged RNAPII complexes at DNA breaks, thereby stimulating nascent transcription at the damaged sites. Of clinical relevance, cancer cells lacking MDC1 display hypersensitivity to RNAPII inhibitors. Overall, we unveil a role of MDC1 in RNAPII-mediated transcription with potential implications for cancer treatment.

Abstract

European Union 722729

Abstract

Danish Cancer Society R167-A11068, R204-A12617-B153, R311-A18224

Abstract

Lundbeck Foundation R266-2017-4289

Abstract

Swedish Research Council VR-MH 2014-46602-117891-30

Abstract

Danish Council for Independent Research DFF-7016-00313

Abstract

Japan Society for the Promotion of Science (JSPS) JP19K23927, JP20K07578

Abstract

Novo Nordisk Foundation NNF20OC0060590, NNF18OC0052647, NNF20OC0059959

Abstract

Independent Research Fund Denmark 8045-00057A, 0165-00092B

Additional details